TRUPANION, INC. (TRUP) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.50%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 2.28×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.50% | Share-based compensation / revenue. Period ending 2026-06-30. $37.99M ÷ $1.52B × 100 ≈ 2.50% |
| Interest coverage · 12 months | 2.28× | Operating income ÷ reported interest expense. $24.15M ÷ $10.57M ≈ 2.28× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 1.52B USD | |
| Stock-based compensation | 37.99M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 24.15M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 10.57M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.52B | $37.99M | $24.15M | $10.57M | (m) | 2.50% | 2.28× | Reported |
| 2026-03-31 | (m) | $1.48B | $37.48M | $20.09M | $12.42M | (m) | 2.53% | 1.62× | Reported |
| 2025-12-31 | (m) | $1.44B | $38.31M | $13.84M | $13.76M | (m) | 2.66% | 1.01× | Reported |
| 2025-09-30 | (m) | $1.40B | $37.08M | $7.05M | $13.11M | (m) | 2.65% | 0.54× | Reported |
| 2025-06-30 | (m) | $1.36B | $35.92M | $2.94M | $14.14M | (m) | 2.64% | 0.21× | Reported |
| 2025-03-31 | (m) | $1.32B | $35.11M | $-4.85M | $14.11M | (m) | 2.66% | -0.34× | Reported |
| 2024-12-31 | (m) | $1.29B | $33.43M | $-9.51M | $14.50M | (m) | 2.60% | -0.66× | Reported |
| 2024-09-30 | (m) | $1.24B | $32.44M | $-9.45M | $14.77M | (m) | 2.61% | -0.64× | Reported |
| 2024-06-30 | (m) | $1.20B | $30.99M | $-14.69M | $14.00M | (m) | 2.58% | -1.05× | Reported |
| 2024-03-31 | (m) | $1.16B | $28.98M | $-22.31M | $13.29M | (m) | 2.50% | -1.68× | Reported |
| 2023-12-31 | (m) | $1.11B | $33.16M | $-40.66M | $12.08M | (m) | 2.99% | -3.37× | Reported |
| 2023-09-30 | (m) | $1.06B | $34.43M | $-50.28M | $9.97M | (m) | 3.25% | -5.05× | Reported |
| 2023-06-30 | (m) | $1.01B | $36.18M | $-58.69M | $8.32M | (m) | 3.59% | -7.05× | Reported |
| 2023-03-31 | (m) | $955.51M | $38.17M | $-58.37M | $6.58M | (m) | 4.00% | -8.88× | Reported |
| 2022-12-31 | (m) | $905.18M | $33.39M | $-43.00M | $4.27M | (m) | 3.69% | -10.08× | Reported |
| 2022-09-30 | (m) | $853.55M | $31.63M | $-39.55M | $2.69M | (m) | 3.71% | -14.71× | Reported |
| 2022-06-30 | (m) | $801.46M | $29.43M | $-34.84M | $1.28M | (m) | 3.67% | -27.20× | Reported |
| 2022-03-31 | (m) | $750.30M | $27.33M | $-31.58M | $87.00K | (m) | 3.64% | -363.00× | Reported |
| 2021-12-31 | (m) | $698.99M | $28.23M | $-35.20M | $10.00K | (m) | 4.04% | -3519.60× | Reported |
| 2021-09-30 | (m) | $647.30M | $24.02M | $-32.60M | $338.00K | (m) | 3.71% | -96.46× | Reported |
| 2021-06-30 | (m) | $595.75M | $20.01M | $-27.67M | $662.00K | (m) | 3.36% | -41.79× | Reported |
| 2021-03-31 | (m) | $545.41M | $15.71M | $-16.65M | $1.00M | (m) | 2.88% | -16.58× | Reported |
| 2020-12-31 | (m) | $502.03M | $8.91M | $-4.93M | $1.38M | (m) | 1.78% | -3.57× | Reported |
| 2020-09-30 | (m) | $464.82M | $8.08M | $-1.13M | $1.42M | (m) | 1.74% | -0.79× | Reported |
| 2020-06-30 | (m) | $433.98M | $7.50M | $1.98M | $1.44M | (m) | 1.73% | 1.38× | Reported |
| 2020-03-31 | (m) | $408.26M | $7.14M | $-1.65M | $1.41M | (m) | 1.75% | -1.17× | Reported |
| 2019-12-31 | (m) | $383.94M | $6.85M | $-1.92M | $1.35M | (m) | 1.78% | -1.42× | Reported |
| 2019-09-30 | (m) | $361.09M | $6.30M | $-2.75M | $1.28M | (m) | 1.74% | -2.14× | Reported |
| 2019-06-30 | (m) | $339.98M | $5.75M | $-2.69M | $1.28M | (m) | 1.69% | -2.10× | Reported |
| 2019-03-31 | (m) | $321.17M | $5.16M | $-832.00K | $1.30M | (m) | 1.61% | -0.64× | Reported |
| 2018-12-31 | (m) | $303.96M | $4.78M | $-1.04M | $1.20M | (m) | 1.57% | -0.87× | Reported |
| 2018-09-30 | (m) | $287.86M | $4.41M | $-2.01M | $1.05M | (m) | 1.53% | -1.91× | Reported |
| 2018-06-30 | (m) | $272.81M | $4.00M | $-2.46M | $838.00K | (m) | 1.47% | -2.93× | Reported |
| 2018-03-31 | (m) | $257.70M | $3.61M | $-2.79M | $615.00K | (m) | 1.40% | -4.53× | Reported |
| 2017-12-31 | (m) | $242.67M | $3.42M | $-2.64M | $533.00K | (m) | 1.41% | -4.96× | Reported |
| 2017-09-30 | (m) | $227.46M | $3.29M | $-3.13M | $451.00K | (m) | 1.45% | -6.95× | Reported |
| 2017-06-30 | (m) | $212.70M | $3.18M | $-5.13M | $393.00K | (m) | 1.49% | -13.06× | Reported |
| 2017-03-31 | (m) | $200.26M | $3.03M | $-5.50M | $325.00K | (m) | 1.51% | -16.93× | Reported |
| 2016-12-31 | (m) | $188.23M | $2.95M | $-6.70M | $218.00K | (m) | 1.57% | -30.72× | Reported |
| 2016-09-30 | (m) | $177.09M | $2.87M | $-8.02M | $164.00K | (m) | 1.62% | -48.92× | Reported |
| 2016-06-30 | (m) | $166.60M | $2.84M | $-11.09M | $111.00K | (m) | 1.71% | -99.92× | Reported |
| 2016-03-31 | (m) | $156.35M | $3.00M | $-14.76M | $110.00K | (m) | 1.92% | -134.15× | Reported |
| 2015-12-31 | (m) | $146.96M | $3.00M | $-16.77M | $325.00K | (m) | 2.04% | -51.62× | Reported |
| 2015-09-30 | (m) | $138.63M | $3.24M | $-17.95M | $401.00K | (m) | 2.34% | -44.77× | Reported |
| 2015-06-30 | (m) | $131.08M | $4.49M | $-18.75M | $5.55M | (m) | 3.43% | -3.38× | Reported |
| 2015-03-31 | (m) | $123.58M | $4.22M | $-17.63M | $6.24M | (m) | 3.41% | -2.83× | Reported |
| 2014-12-31 | $9.90M | $115.91M | $4.08M | $-15.95M | $6.73M | 8.54% | 3.52% | -2.37× | Reported |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $91.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $4.89M | $83.83M | $1.94M | $-6.99M | $609.00K | 5.83% | 2.31% | -11.47× | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $3.41M | $55.53M | $1.43M | $-5.54M | $535.00K | 6.13% | 2.58% | -10.35× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |